Anti-PLLP monoclonal antibody

Pre-made anti-PLLP monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PLLP/PLLP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1415-Ab-1/ GM-Tg-hg-IP1415-Ab-2Anti-Human PLLP monoclonal antibodyHuman
GM-Tg-rg-IP1415-Ab-1/ GM-Tg-rg-IP1415-Ab-2Anti-Rat PLLP monoclonal antibodyRat
GM-Tg-mg-IP1415-Ab-1/ GM-Tg-mg-IP1415-Ab-2Anti-Mouse PLLP monoclonal antibodyMouse
GM-Tg-cynog-IP1415-Ab-1/ GM-Tg-cynog-IP1415-Ab-2Anti-Cynomolgus/ Rhesus macaque PLLP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1415-Ab-1/ GM-Tg-felg-IP1415-Ab-2Anti-Feline PLLP monoclonal antibodyFeline
GM-Tg-cang-IP1415-Ab-1/ GM-Tg-cang-IP1415-Ab-2Anti-Canine PLLP monoclonal antibodyCanine
GM-Tg-bovg-IP1415-Ab-1/ GM-Tg-bovg-IP1415-Ab-2Anti-Bovine PLLP monoclonal antibodyBovine
GM-Tg-equg-IP1415-Ab-1/ GM-Tg-equg-IP1415-Ab-2Anti-Equine PLLP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1415-Ab-1/ GM-Tg-hg-IP1415-Ab-2; GM-Tg-rg-IP1415-Ab-1/ GM-Tg-rg-IP1415-Ab-2;
GM-Tg-mg-IP1415-Ab-1/ GM-Tg-mg-IP1415-Ab-2; GM-Tg-cynog-IP1415-Ab-1/ GM-Tg-cynog-IP1415-Ab-2;
GM-Tg-felg-IP1415-Ab-1/ GM-Tg-felg-IP1415-Ab-2; GM-Tg-cang-IP1415-Ab-1/ GM-Tg-cang-IP1415-Ab-2;
GM-Tg-bovg-IP1415-Ab-1/ GM-Tg-bovg-IP1415-Ab-2; GM-Tg-equg-IP1415-Ab-1/ GM-Tg-equg-IP1415-Ab-2
Products NameAnti-PLLP monoclonal antibody
Formatmab
Target NamePLLP
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PLLP monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1415-Ag-1Recombinant multi-species PLLP/ PMLP/ ™4SF11 protein
    ORF Viral VectorvGMLP000672human PLLP Lentivirus particle
    ORF Viral VectorpGMLP000672human PLLP Lentivirus plasmid


    Target information

    Target IDGM-IP1415
    Target NamePLLP
    Gene ID51090,67801,64364,704120,100685289,101084409,613446,100062302
    Gene Symbol and Synonyms0610010I06Rik,Plapi,PLLP,PMLP,™4SF11
    Uniprot AccessionQ9Y342,P47987,A6H7B0
    Uniprot Entry NamePLLP_HUMAN,PLLP_RAT,PLLP_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000102934
    Target ClassificationIon Channel

    The target: PLLP, gene name: PLLP, also named as PMLP, ™4SF11. Predicted to be a structural constituent of myelin sheath. Predicted to be involved in myelination. Predicted to be located in compact myelin and membrane raft. Predicted to be integral component of membrane. Biomarker of schizophrenia. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.